BNP Paribas Financial Markets
PRCT icon

BNP Paribas Financial Markets’s Procept Biorobotics PRCT Stock Holding History

BNP Paribas Financial Markets’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.96M Sell
198,150
-9,826
-5% -$277K ﹤0.01% 2028
2025
Q4 		$6.54M Buy
207,976
+115,996
+126% +$3.85M ﹤0.01% 1866
2025
Q3 		$3.28M Buy
91,980
+48,281
+110% +$2.2M ﹤0.01% 2266
2025
Q2 		$2.52M Sell
43,699
-21,942
-33% -$1.24M ﹤0.01% 2322
2025
Q1 		$3.82M Sell
65,641
-77,185
-54% -$5.27M ﹤0.01% 1975
2024
Q4 		$11.5M Buy
+142,826
New +$12.2M 0.01% 1273
2022
Q4 		– Sell
-18,454
Closed -$765K – 4472
2022
Q3 		$765K Buy
+18,454
New +$736K ﹤0.01% 2685

Other funds holding PRCT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return